Cell and Gene Therapy Development
Genedata Selector® supports the analysis and interpretation of NGS data for cell and gene therapy development. Key applications include Critical Quality Attribute (CQA) assessment confirming identity, biosafety, and potency to accelerate the delivery of safe and efficacious therapies to patients in need.
Streamline CGT Manufacturing Processes
Genedata Selector enables automation and standardization of NGS-based cell and gene therapy assays.
This out-of-the-box support includes safety assays, sequence characterization, and potency assessment.
Ensure Mycoplasma-Free CGT
When used to analyze NGS data, Genedata Selector provides a comprehensive solution for detecting adventitious agents, such as mycoplasma, throughout the CGT development process.
Learn in 3 minutes how our platform helps to ensure mycoplasma-free cell and gene therapy products:
Confirm the Integrity of Viral Vectors
Actionable go/no-go signals provided by Genedata Selector leads to faster and better informed decisions regarding sequence integrity of viral vectors.
Learn in 3 minutes how to streamline decision-making for safe CGT development:
Assess Potency with scRNAseq Analysis
Genedata Selector supports single cell RNAseq data analyses to streamline your decision-making using the informative and interactive data display.
Learn in 3 minutes how to determine identity and potency of your cells' populations: